Showing results (61-70 of 209) with videos related to

Sort By:
Pageof 21
Blood Advances|July 3, 2025
Age-Adjusted Dosing of Fludarabine for Lymphodepletion in CAR T-cell Therapy: A Clinical Trial Simulation StudyJohn C Panetta, Aimee C Talleur, Swati Naik, et al.
JCI Insight|November 5, 2020
MyD88/CD40 signaling retains CAR T cells in a less differentiated stateBrooke Prinzing, Patrick Schreiner, Matthew Bell, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironmentAdeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Cancer Gene Therapy|September 3, 2020
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumoursKenneth Hsu, Shiloh Middlemiss, Federica Saletta, et al.
Nature Biotechnology|February 2, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activityPeter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute, et al.
Cancer Discovery|February 10, 2021
A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell FunctionShannon Lange, Laurens G L Sand, Matthew Bell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cellsAnn Leen, Maheshika Ratnayake, Aaron Foster, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Pageof 21